A civil investigative demand or a qui tam complaint under the False Claims Act rarely arrives as a finished lawsuit. It typically starts as a letter, a subpoena, or a sealed complaint the organization does not learn of until the government's investigation surfaces it. Whether a directors and officers (D&O) or regulatory liability policy pays the legal costs of responding depends on definitions most compliance officers never read until the demand is already on their desk: what counts as a claim, which exclusions apply, and how the policy allocates between defense costs and any eventual settlement or judgment.
D&O and Regulatory Coverage for FCA Defense Costs
D&O and regulatory liability policies can respond to False Claims Act exposure by advancing the cost of counsel once a covered claim is made, but coverage at the investigative stage is frequently disputed. Courts examining this question have found that where a policy defines "claim" broadly enough to include a written demand for non-monetary relief or an investigation, a civil investigative demand (CID) can itself trigger the duty to defend, entitling the insured to defense cost coverage for responding to the demand, according to a Morgan Lewis analysis of recent Delaware coverage rulings. Policies with a narrower claim definition, tied to a filed civil proceeding, generally do not respond until the complaint is unsealed.
Fraud Exclusions, Severability, and Allocation
Standard fraud and dishonesty exclusions bar coverage for the underlying conduct, but most are written to apply only after a final adjudication establishes that the excluded conduct actually occurred, so defense costs continue to be advanced through the litigation, subject to repayment if the exclusion is ultimately triggered. A severability clause keeps one officer's alleged misconduct from being imputed to co-insureds who were not involved. Coverage questions sharpen further at allocation: defense costs are generally distinct from treble damages, per-claim civil penalties, and disgorgement, and one federal appeals court has held that FCA settlement payments are not automatically uninsurable restitution, because courts look to the substance of the payment rather than its label. That inquiry runs alongside the separate question of whether the underlying exposure is civil or criminal, since criminal healthcare fraud charges sit outside what any D&O or regulatory policy is written to cover.
Defense cost coverage and coverage for an eventual settlement are two different questions, and a policy that funds the investigation does not necessarily fund the outcome.
Notice Obligations Under a Claims-Made Policy
Most D&O and regulatory policies are written on a claims-made basis, which means the date the organization first receives a demand, subpoena, or unsealed complaint controls, and notice to the carrier must go out within the window the policy states, sometimes as short as 30 or 60 days. Because FCA complaints are filed under seal, an organization may not learn a claim exists until a CID arrives or the case is unsealed, and the notice clock can already be running by then. Late notice under a claims-made policy is treated differently than under an occurrence policy: many jurisdictions do not require the insurer to show it was prejudiced by the delay before denying coverage outright, so the safer course is to tender notice to every potentially applicable policy as soon as an investigative demand is received.
Why Early Legal Counsel Is Critical
It is critical that healthcare organizations promptly retain experienced healthcare defense counsel upon receiving a subpoena, civil investigative demand, audit notice, or other government inquiry, and that counsel is brought in early enough to help identify every policy that may respond and to preserve the organization's notice rights under each one. Early legal intervention can protect the organization's rights, ensure appropriate responses to government requests, avoid inadvertent admissions, and let counsel communicate with investigators and insurers on the organization's behalf. Delaying representation, or delaying notice to a carrier, can significantly affect both the legal outcome and what portion of the defense is ultimately covered.
How Health Law Alliance Can Help
Health Law Alliance defends healthcare organizations and their executives against False Claims Act investigations and qui tam suits, and works alongside coverage counsel and carriers to help clients understand what a given D&O or regulatory policy actually funds at each stage of a matter. If your organization has received a civil investigative demand, a subpoena, or notice of a qui tam action, contact us for a free, confidential consultation.
